1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Inclusion and exclusion criteria for treatment with FRED
Criteria In favor of treatment with FRED Intradural incidental aneurysm Intradural or extradural symptomatic aneurysm (mass effect) Supposed difficulty for coil treatment alone (dome-to-neck ratio of <1.2, broad-based aneurysm, fusiform morphology, blisterlike shape) Difficulty or impossibility of neurosurgical clip placement due to aneurysm morphology or anatomic location Acutely ruptured aneurysms without any alternative neurosurgical or endovascular treatment option Aneurysm remnant or reperfusion after endovascular or microsurgical treatment Documented response to medicamentous platelet function inhibition Exclusion for treatment with FRED Intradural aneurysm with a definable neck Intradural bifurcation aneurysm Documented nonresponse to medicamentous platelet function inhibition Patient preference for alternative treatment options Patient preference against any treatment